# Biotech Daily Digest â€” 2025-10-16

**43 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 1 item
- Endpoints News: 10 items
- Fierce Biotech: 6 items
- MHRA â€“ News: 4 items
- arXiv q-bio: 22 items


## Eli Lilly Press Releases

- **[Lilly confirms date and conference call for third-quarter 2025 financial results announcement](https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-third-quarter-2025)**  
  _Thu, 16 Oct 2025 10:00:00 -0400_  
  INDIANAPOLIS , Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025 . Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial


## Endpoints News

- **[Dianthus inks licensing deal with Chinese biotech; C4 targets $125M offering](https://endpoints.news/dianthus-inks-licensing-deal-with-chinese-biotech-c4-targets-125m-offering/)**  
  _Thu, 16 Oct 2025 14:32:04 +0000_  
  Plus, news about Merck, Beijing Jacobio, Immunai, BridGene Biosciences and Spyre Therapeutics:

 ðŸ‡¨ðŸ‡³ Dianthus Therapeutics licenses autoimmune asset from China: The biotech will pay $30 million upfront to Nanjing Leads Biolabs ...

- **[How wearable maker Whoop is making its move into healthcare](https://endpoints.news/how-wearable-maker-whoop-is-making-its-move-into-healthcare/)**  
  _Thu, 16 Oct 2025 14:30:34 +0000_  
  The consumer wearable company Whoop is following a broader industry trend to push from wellness into healthcare this year.

 Valued at $3.6 billion after a 2021 Series F funding round, one of the Boston-based company' ...

- **[AstraZeneca opens $445M expansion of Lokelma factory; Avidity Bio delays BLA for Duchenne drug](https://endpoints.news/astrazeneca-opens-445m-expansion-of-lokelma-factory-avidity-bio-delays-bla-for-duchenne-drug/)**  
  _Thu, 16 Oct 2025 14:16:53 +0000_  
  Welcome to Endpoints Newsâ€™ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

 AstraZeneca has opened its expanded Coppell, TX, facility which makes its hyperkalemia ...

- **[Novartisâ€™ Fabhalta gets confirmatory late-stage trial win in kidney disease IgAN](https://endpoints.news/novartis-fabhalta-gets-confirmatory-late-stage-trial-win-in-kidney-disease-igan/)**  
  _Thu, 16 Oct 2025 13:03:03 +0000_  
  Novartis expects Fabhaltaâ€™s accelerated approval in the kidney disease known as IgA nephropathy to be converted into a full approval after the drug met its primary endpoint in a confirmatory Phase 3 trial.

 The complement ...

- **[Connecticut biotech Veradermics gets $150M for Phase 3 trials of oral Rogaine](https://endpoints.news/connecticut-biotech-gets-150m-for-phase-3-trials-of-oral-rogaine/)**  
  _Thu, 16 Oct 2025 11:30:36 +0000_  
  Veradermics has raised the week's second megaround for a hair loss biotech, collecting a $150 million Series C from prominent life sciences investors.

 The New Haven, CT-based biotech plans to use the funding to get ...

- **[Adcytherix raises â‚¬104M Series A to back new ADC drug](https://endpoints.news/adcytherix-raises-e104m-series-a-to-back-new-adc-drug/)**  
  _Thu, 16 Oct 2025 09:00:55 +0000_  
  A French team of researchers and biopharma executives is taking the wraps off a large Series A round that will help get its lead antibody-drug conjugate program into its first human trials.

 Adcytherix unveiled its ...

- **[Aicuris' herpes drug succeeds in Phase 3 study, company says](https://endpoints.news/aicuris-herpes-drug-succeeds-in-phase-3-study-company-says/)**  
  _Thu, 16 Oct 2025 09:00:40 +0000_  
  A privately-held German biotech said its experimental herpes drug succeeded in a Phase 3 study, setting up plans to apply for US approval in 2026.

 Patients on Aicuris' drug, called pritelivir, outperformed those in a ...

- **[Peter Thiel-backed Peptilogics raises $78M for prosthetic joint infection program](https://endpoints.news/peter-thiel-backed-peptilogics-raises-78m-for-prosthetic-joint-infection-program/)**  
  _Thu, 16 Oct 2025 09:00:13 +0000_  
  A Pittsburgh-based biotech supported by PayPal co-founder Peter Thiel has secured $78 million in a Series B raise that will focus on advancing its candidate for prosthetic joint infections.

 The cash will support a registrational ...

- **[BioNTech to get up to â‚¬95M in EU funding for a mRNA vaccine site in Africa](https://endpoints.news/biontech-to-get-up-to-e95m-in-eu-funding-for-a-mrna-vaccine-site-in-africa/)**  
  _Wed, 15 Oct 2025 16:07:33 +0000_  
  Two EU bodies will fund BioNTech with up to â‚¬95 million ($110 million) to help build its mRNA vaccine factory in Kigali, Rwanda, which is designed to locally supply vaccines to Africa.

 The Mainz, Germany ...

- **[Lillyâ€™s oral GLP-1 racks up two more clinical wins in diabetes](https://endpoints.news/lillys-oral-glp-1-racks-up-two-more-clinical-wins-in-diabetes/)**  
  _Wed, 15 Oct 2025 14:51:43 +0000_  
  Eli Lillyâ€™s GLP-1 pill has succeeded in two more late-stage trials in type 2 diabetes.

 The company said Wednesday that orforglipron beat AstraZenecaâ€™s Farxiga at lowering patientsâ€™ blood sugar levels in ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/sanofi-inks-500m-deal-evoq-next-gen-autoimmune-tech" hreflang="en">Sanofi inks $500M deal with Evoq for next-gen autoimmune tech </a>](https://www.fiercebiotech.com/biotech/sanofi-inks-500m-deal-evoq-next-gen-autoimmune-tech)**  
  _Oct 16, 2025 9:40am_  
  University of Michigan spinout Evoq Therapeutics has struck its third major partnership with a biopharma powerhouse, signing on with Sanofi in a deal worth up to $500 million. The agreement comes after Evoq entered deals with Gilead Sciences in 2023 and Amgen in 2021.

- **[<a href="https://www.fiercebiotech.com/biotech/astrazeneca-pens-fresh-ibd-collab-long-term-ai-partner-immunai-worth-85m" hreflang="en">AstraZeneca pens fresh IBD collab with long-term AI partner Immunai worth $85M</a>](https://www.fiercebiotech.com/biotech/astrazeneca-pens-fresh-ibd-collab-long-term-ai-partner-immunai-worth-85m)**  
  _Oct 16, 2025 3:51am_  
  AstraZeneca has returned to its longtime AI partner Immunai with a new deal worth up to $85 million to advance a target for a new inflammatory bowel disease therapy.

- **[<a href="https://www.fiercebiotech.com/pharma/veradermic-looking-tousle-hair-loss-market-locks-down-150m-series-c" hreflang="en">Veradermics, looking to tousle the pattern hair loss market, locks down $150M series C </a>](https://www.fiercebiotech.com/pharma/veradermic-looking-tousle-hair-loss-market-locks-down-150m-series-c)**  
  _Oct 15, 2025 3:50pm_  
  Veradermics will use the funding to support further phase 3 development for its extended-release formulation of oral minoxidil, a decades-old hypertension treatment that's commonly used off-label for hair loss.

- **[<a href="https://www.fiercebiotech.com/biotech/aicuris-antiviral-scores-phase-3-hsv-trial-setting-fda-filing" hreflang="en">Aicuris antiviral scores in phase 3 HSV trial, setting up FDA filing</a>](https://www.fiercebiotech.com/biotech/aicuris-antiviral-scores-phase-3-hsv-trial-setting-fda-filing)**  
  _Oct 14, 2025 4:56pm_  
  Aicuris has reported the success of a phase 3 trial, which has demonstrated the superiority of oral antiviral pritelivir compared to standard-of-care treatments in healing lesions of immunocompromised patients with refractory HSV infections. The study paves the way for an FDA new drug application, the German company sâ€¦

- **[<a href="https://www.fiercebiotech.com/medtech/boehringer-click-release-trial-results-digital-app-treat-negative-symptoms-schizophrenia" hreflang="en">Boehringer, Click's digital therapeutic meets phase 3 goal in schizophrenia</a>](https://www.fiercebiotech.com/medtech/boehringer-click-release-trial-results-digital-app-treat-negative-symptoms-schizophrenia)**  
  _Oct 14, 2025 12:12pm_  
  German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint.

- **[<a href="https://www.fiercebiotech.com/medtech/roche-nabs-fda-clearance-alzheimers-biomarker-blood-test" hreflang="en">Roche nabs FDA clearance for Alzheimer's biomarker blood test</a>](https://www.fiercebiotech.com/medtech/roche-nabs-fda-clearance-alzheimers-biomarker-blood-test)**  
  _Oct 14, 2025 11:14am_  
  Roche, which currently has investigational Alzheimerâ€™s disease drug trontinemab in phase 3 trials, secured FDA clearance for its blood-based biomarker test for the condition.


## MHRA â€“ News

- **[Guidance: Innovative Licensing and Access Pathway (ILAP)](https://www.gov.uk/government/publications/innovative-licensing-and-access-pathway-ilap)**  
  _2025-10-16T10:42:07Z_  
  The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.

- **[Guidance: AI Airlock Phase 2 Cohort](https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort)**  
  _2025-10-16T08:28:39Z_  
  Phase 2 of the Airlock will include seven additional technologies spanning AI-powered clinical note taking, advanced cancer diagnostics, eye disease detection tools, and obesity treatment support systems.

- **[Guidance: AI Airlock Simulation Workshops](https://www.gov.uk/government/publications/ai-airlock-simulation-workshops)**  
  _2025-10-16T08:26:31Z_  
  Key insights of three simulation workshops from the AI Airlock pilot testing programme. Please note that these documents are not formal guidance.

- **[Professor James Levine: When policy becomes medicine](https://www.gov.uk/government/news/professor-james-levine-when-policy-becomes-medicine)**  
  _2025-10-16T08:01:33Z_  
  How regulation can spark life-saving innovation.


## arXiv q-bio

- **[ST2HE: A Cross-Platform Framework for Virtual Histology and Annotation of High-Resolution Spatial Transcriptomics Data](https://arxiv.org/abs/2510.12840)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.12840v1 Announce Type: new 
Abstract: High-resolution spatial transcriptomics (HR-ST) technologies offer unprecedented insights into tissue architecture but lack standardized frameworks for histological annotation. We present ST2HE, a cross-platform generative framework that synthesizes virtual hematoxylinâ€¦

- **[Protenix-Mini+: efficient structure prediction model with scalable pairformer](https://arxiv.org/abs/2510.12842)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.12842v1 Announce Type: new 
Abstract: Lightweight inference is critical for biomolecular structure prediction and downstream tasks, enabling efficient real-world deployment and inference-time scaling for large-scale applications. While AF3 and its variants (e.g., Protenix, Chai-1) have advanced structure prâ€¦

- **[Likelihood-free inference of phylogenetic tree posterior distributions](https://arxiv.org/abs/2510.12976)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.12976v1 Announce Type: new 
Abstract: Phylogenetic inference, the task of reconstructing how related sequences evolved from common ancestors, is a central task in evolutionary genomics. The current state-of-the-art methods exploit probabilistic models of sequence evolution along phylogenetic trees, by searcâ€¦

- **[Using transient encounter rates to quantify spatial patterns of home-range organization](https://arxiv.org/abs/2510.13017)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13017v1 Announce Type: new 
Abstract: Encounters between individuals underlie key ecological processes such as predation, mating, and disease transmission, making encounter rates a direct link between individual movement behavior and population-level outcomes. We investigate how two common features of animaâ€¦

- **[Omni-QALAS: Optimized Multiparametric Imaging for Simultaneous T1, T2 and Myelin Water Mapping](https://arxiv.org/abs/2510.13118)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13118v1 Announce Type: new 
Abstract: Purpose: To improve the accuracy of multiparametric estimation, including myelin water fraction (MWF) quantification, and reduce scan time in 3D-QALAS by optimizing sequence parameters, using a self-supervised multilayer perceptron network. Methods: We jointly optimizeâ€¦

- **[Precision Design of Cyclic Peptides using AlphaFold](https://arxiv.org/abs/2510.13127)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13127v1 Announce Type: new 
Abstract: This independent research investigates methods to improve the precision of cyclic peptide generation targeting the HIV gp120 trimer using AlphaFold. The study explores proximity-based hotspot mapping at the CD4 binding site, centroid distance penalization, generative loâ€¦

- **[Bifurcation of spiking oscillations from a center in resonate-and-fire neurons](https://arxiv.org/abs/2510.13156)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13156v1 Announce Type: new 
Abstract: The theta rhythm is important for many cognitive functions including spatial processing, memory encoding, and memory recall. The information processing underlying these functions is thought to rely on consistent, phase-specific spiking throughout a theta oscillation thaâ€¦

- **[Power-laws in phylogenetic trees and the preferential coalescent](https://arxiv.org/abs/2510.13270)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13270v1 Announce Type: new 
Abstract: Phylogenetic trees capture evolutionary relationships among species and reflect the forces that shaped them. While many studies rely on branch length information, the topology of phylogenetic trees (particularly their degree of imbalance) offers a robust framework for iâ€¦

- **[qLOOK: A Minimal Information System for Digital Storage and Reproducible Analysis of qPCR experiments](https://arxiv.org/abs/2510.13520)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13520v1 Announce Type: new 
Abstract: Objective: Quantitative real-time PCR is widely used for gene expression analysis, yet inconsistencies in data storage and reporting limit reproducibility. While MIQE guidelines define the minimal information required for publication, they do not specify structured digiâ€¦

- **[Jacobian-Based Interpretation of Nonlinear Neural Encoding Model](https://arxiv.org/abs/2510.13688)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13688v1 Announce Type: new 
Abstract: In recent years, the alignment between artificial neural network (ANN) embeddings and blood oxygenation level dependent (BOLD) responses in functional magnetic resonance imaging (fMRI) via neural encoding models has significantly advanced research on neural representatiâ€¦

- **[Modeling Adoptive Cell Therapy in Bladder Cancer from Sparse Biological Data using PINNs](https://arxiv.org/abs/2510.13431)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13431v1 Announce Type: cross 
Abstract: Physics-informed neural networks (PINNs) are neural networks that embed the laws of dynamical systems modeled by differential equations into their loss function as constraints. In this work, we present a PINN framework applied to oncology. Here, we seek to learn time-â€¦

- **[A Quantitative Holographic Agglutination Assay for Immunoglobulin A](https://arxiv.org/abs/2510.13480)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13480v1 Announce Type: cross 
Abstract: This study introduces a Holographic Agglutination Assay for quantifying levels of the immunoglobulin protein IgA in biological samples. This is the first example of a label-free and bead-free assay that quantifies protein agglutinates by direct detection using Total Hâ€¦

- **[Data-Driven Reduced Modeling of Recurrent Neural Networks](https://arxiv.org/abs/2510.13519)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13519v1 Announce Type: cross 
Abstract: Artificial Recurrent Neural Networks (RNNs) are widely used in neuroscience to model the collective activity of neurons during behavioral tasks. The high dimensionality of their parameter and activity spaces, however, often make it challenging to infer and interpret tâ€¦

- **[Spherical Radiomics - A Novel Approach to Glioblastoma Radiogenomic Analysis of Heterogeneity](https://arxiv.org/abs/2510.13658)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13658v1 Announce Type: cross 
Abstract: We develop and validate a novel spherical radiomics framework for predicting key molecular biomarkers using multiparametric MRI. Conventional Cartesian radiomics extract tumor features on orthogonal grids, which do not fully capture the tumor's radial growth patternsâ€¦

- **[Hierarchical Bayesian Modeling of Dengue in Recife, Brazil (2015-2024): The Role of Spatial Granularity and Data Quality for Epidemiological Risk Mapping](https://arxiv.org/abs/2510.13672)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13672v1 Announce Type: cross 
Abstract: Dengue remains one of Brazil's major epidemiological challenges, marked by strong intra-urban inequalities and the influence of climatic and socio-environmental factors. This study analyzed confirmed dengue cases in Recife from 2015 to 2024 using a Bayesian hierarchicâ€¦

- **[Scaling Vision Transformers for Functional MRI with Flat Maps](https://arxiv.org/abs/2510.13768)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2510.13768v1 Announce Type: cross 
Abstract: A key question for adapting modern deep learning architectures to functional MRI (fMRI) is how to represent the data for model input. To bridge the modality gap between fMRI and natural images, we transform the 4D volumetric fMRI data into videos of 2D fMRI activity fâ€¦

- **[Stochastic Models for Replication Origin Spacings in Eukaryotic DNA Replication](https://arxiv.org/abs/2209.09680)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2209.09680v4 Announce Type: replace 
Abstract: Replication of genetic material is an important process for all living organisms. Origins of replication initiate the copying of DNA at many points on a chromosome, and it is the distribution of these points that is relevant here, as it presents us with an interestiâ€¦

- **[Branch length statistics in phylogenetic trees under constant-rate birth-death dynamics](https://arxiv.org/abs/2407.13403)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2407.13403v4 Announce Type: replace 
Abstract: Phylogenetic trees represent the evolutionary relationships between extant lineages, where extinct or non-sampled lineages are omitted. Extending the work of Stadler and collaborators, this paper focuses on the branch lengths in phylogenetic trees arising under a coâ€¦

- **[Attractive and Repulsive Perceptual Biases Naturally Emerge in Generative Adversarial Inference](https://arxiv.org/abs/2507.19944)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2507.19944v2 Announce Type: replace 
Abstract: Perceptual estimates exhibit a reversal in bias depending on uncertainty: they shift toward prior expectations under high stimulus noise, but away from them when sensory noise dominates. The normative framework of a Bayesian observer model can account for this phenoâ€¦

- **[Software System for Low-Cost, GUI-Based Microscopy Segmentation: Algorithmic Implementation](https://arxiv.org/abs/2509.11354)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2509.11354v3 Announce Type: replace 
Abstract: This article presents a novel microscopy image analysis framework designed for low-budget labs equipped with a standard CPU desktop. The Python-based program enables cytometric analysis of live, unstained cells in culture through an advanced computer vision and machâ€¦

- **[Of Mice and Machines: A Comparison of Learning Between Real World Mice and RL Agents](https://arxiv.org/abs/2505.12204)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2505.12204v3 Announce Type: replace-cross 
Abstract: Recent advances in reinforcement learning (RL) have demonstrated impressive capabilities in complex decision-making tasks. This progress raises a natural question: how do these artificial systems compare to biological agents, which have been shaped by millionsâ€¦

- **[Enabling Few-Shot Alzheimer's Disease Diagnosis on Biomarker Data with Tabular LLMs](https://arxiv.org/abs/2507.23227)**  
  _Thu, 16 Oct 2025 00:00:00 -0400_  
  arXiv:2507.23227v2 Announce Type: replace-cross 
Abstract: Early and accurate diagnosis of Alzheimer's disease (AD), a complex neurodegenerative disorder, requires analysis of heterogeneous biomarkers (e.g., neuroimaging, genetic risk factors, cognitive tests, and cerebrospinal fluid proteins) typically represented inâ€¦
